Insider filing · KYMR
Jeremy G Chadwick
Chief Operating Officer
profile →
Kymera Therapeutics, Inc.
KYMR · Healthcare · 58 filings in 24 months
ticker →
Jeremy G Chadwick sold $1.3M of Kymera Therapeutics (KYMR)
Executed May 26, disclosed May 27, 1 day later.
Value, as filed
$1.3M
15,709 sh across 4 lots
Executed
May 26
the trade date, as filed
Disclosed
May 27
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JCJeremy G Chadwick (Chief Operating Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $9.0M of KYMR (114,777 sh across 5 lots, as filed), executed Mar 23.
The name
KYMRHealthcare · Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jeremy G Chadwick in KYMR
KYMRSALE
Kymera Therapeutics, Inc.
$590K6,551 sh across 2 lots
Exec Apr 14
Filed Apr 16 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $1.8M
21,140 sh across 2 lots
Exec Mar 31
Filed Apr 1 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $9.0M
114,777 sh across 5 lots
Exec Mar 23
Filed Mar 25 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $2.1M
25,758 sh across 3 lots
Exec Mar 11
Filed Mar 11 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $172K
2,017 sh × $85.04
Exec Mar 4
Filed Mar 4 · 5:30 PM ET